ESMO Asia 2019 Congress - Information for Media Representatives

Media registration

ESMO welcomes media interested in obtaining information and reporting on cancer issues. Registration is free to bona fide journalists on presentation of a letter of assignment and a valid press card. Media representatives are required to observe and abide by the ESMO Media Policy which applies to all ESMO events.

To register for the event, please fill out the Media Registration Form

Complete the Media Registration Form

Media registration in advance is strongly recommended although on-site registration will still be possible. Further information for press representatives will be made available over the following weeks.

Publication schedule for accepted abstracts

Deadline Date and time

Abstracts accepted as:

  • Proffered Paper (suffix ‘O’)
  • Mini oral (suffix ‘O’)
  • Poster (suffix ‘P’)
Wednesday, 20 November 2019, 00:05 hrs SGT (local Singapore Time)
Tuesday, 19 November 2019, 17:05 hrs CET (Central European Time) 
Late-breaking abstracts (prefix ‘LBA’) 00:05 hrs SGT (local Singapore Time) on the day of presentation during the official ESMO Asia 2019 Congress programme.
Abstracts and LBAs selected for the official ESMO
Press Programme (additional suffix ‘PR’)
ESMO Press Programme and related abstract publication schedule, will be available 10 days before the Congress

Press releases

The following abstracts will be accompanied by a press release available at embargo lift.

Upon publication, direct link to the press releases will be added.

FPN Title Author name Embargo lift and press release distribution date/time
LBA3 Atezolizumab (atezo) + bevacizumab (bev) vs sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC): Phase 3 results from IMbrave150 AL. Cheng Saturday 23 November 2019, 00:05 SGT (local Singapore Time) corresponding to 
Friday 22 November 2019, 17:05 CET (Central European Time)
LBA6 First China-manufactured trastuzumab biosimilar HLX02 global phase III trial met primary endpoint in breast cancer B. Xu Saturday 23 November 2019, 00:05 SGT (local Singapore Time) corresponding to 
Friday 22 November 2019, 17:05 CET (Central European Time)

Third-party media activities

Media activities initiated by third parties during or in connection with ESMO Asia 2019 Congress, including, but not limited to:

  • Meetings such as press conferences, media briefings, educational sessions for media representatives, as well as
  • PR activities, such as press releases, news, articles, interviews, etc.

are subject to the  ESMO Policy on Third-Party Media Activities. This policy aims to guarantee proper and correct distribution of oncology and cancer-related information to media representatives in connection with the conference. Press events in or outside the congress centre but concomitant with/or during breaks of the scientific programme of ESMO Asia 2019 Congress are subject to ESMO Press Office approval. Please submit your first request through the following form.

Blackout times

During Blackout times any media activity initiated by third parties is not allowed.

Day Time
Friday, 22 November 2019 09:45-18:00
Saturday, 23 November 2019 08:00-19:15
Sunday, 24 November 2019 09:00-16:30

Contacts

ESMO Press Office
E-mail:  media@esmo.org

Ying Communications has been officially appointed as ESMO communication agency in Singapore for the ESMO Asia Congress 2019​
Email: Ying Communications